• Open Access

COX-2 in the neurodegenerative process of Parkinson's disease

Authors

  • Peter Teismann

    Corresponding author
    1. School of Medical Sciences, College of Life Sciences and Medicine, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK
    • University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK
    Search for more papers by this author
    • Tel.: +44-(0)1224-437325; Fax: +44-(0)1224-437465


Abstract

The enzyme cyclooxygenase-2 (COX-2), responsible for the first committed step in the synthesis of several important mediators which are involved in both initiation and resolution of inflammation, and the subsequent generation of prostaglandins (PGs) upon activation has been shown to participate in the neurodegenerative processes of a variety of diseases. This review looks particular at the role of COX-2 in the pathogenesis of Parkinson's disease, involving the generation of PGs and the role of the two different parts of the cyclooxygenase—cyclooxygenase and peroxidase activity. © 2012 International Union of Biochemistry and Molecular Biology, Inc.

Ancillary